American College of Cardiology: Tricuspid Valve Treatments Safe, Effective and Improve Quality of Life
October 31, 2024
October 31, 2024
WASHINGTON, Oct. 31 -- The American College of Cardiology issued the following news release:
* * *
JACC papers show one-year safety, QOL data for new FDA approved treatments and European treatment, provide comprehensive overview of TTVR
* * *
Two FDA approved devices for tricuspid regurgitation are safe, effective and improve quality of life at one-year according to studies published in JACC, the flagship journal of the American College of Card . . .
* * *
JACC papers show one-year safety, QOL data for new FDA approved treatments and European treatment, provide comprehensive overview of TTVR
* * *
Two FDA approved devices for tricuspid regurgitation are safe, effective and improve quality of life at one-year according to studies published in JACC, the flagship journal of the American College of Card . . .